Biocept Important In The Fight Against Breast Cancer: Is 2021 An Essential Year?
BIOC

Biocept Inc. ($BIOC) recently released its third-quarter results, which showed that revenue had quadrupled year-over-year (revenues of $6.6 million). This was explained by analysts on the basis of a strategically strong move by offering a molecular diagnostics to test the coronavirus (RT-PCR test). Offering COVID-19 testing services has been the right choice and is expected…